Copyright
©The Author(s) 2017.
World J Gastroenterol. Jan 7, 2017; 23(1): 135-140
Published online Jan 7, 2017. doi: 10.3748/wjg.v23.i1.135
Published online Jan 7, 2017. doi: 10.3748/wjg.v23.i1.135
Figure 1 Correlation of serum trefoil factor-3 concentrations with Simple Endoscopic Score for Crohn’s disease scores.
Samples were collected from 29 patients before and after the induction therapy with anti-TNF-α agents (n = 58). TFF-3: Trefoil factor-3; SES-CD: Simple Endoscopic Score for Crohn’s disease.
Figure 2 Individual changes in serum trefoil factor-3 during anti-TNF-α therapy in patients with or without successful mucosal healing as assessed by endoscopy.
MH: Mucosal healing; TFF-3: Trefoil factor-3.
Figure 3 Correlation of fecal calprotectin with Simple Endoscopic Score for Crohn’s disease and serum trefoil factor-3 in 10 patients assessed before and after the induction therapy with anti-TNF-α agents (n = 20).
TFF-3: Trefoil factor-3; SES-CD: Simple Endoscopic Score for Crohn’s Disease; FC: Fecal calprotectin.
- Citation: Eder P, Stawczyk-Eder K, Korybalska K, Czepulis N, Luczak J, Lykowska-Szuber L, Krela-Kazmierczak I, Linke K, Witowski J. Trefoil factor-3 is not a useful marker of mucosal healing in Crohn's disease treated with anti-TNF-α antibodies. World J Gastroenterol 2017; 23(1): 135-140
- URL: https://www.wjgnet.com/1007-9327/full/v23/i1/135.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i1.135